Sec Form 13G Filing - Lind Global Fund II LP filing for PaxMedica, Inc. Common Stock (PXMD) - 2025-02-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  (1) The reporting person's ownership consists of (i) 191,770 shares of common stock, (ii) 961,540 warrants to purchase shares of common stock (the "New Warrants"), and (iii) 47,059 warrants to purchase shares of common stock (the "Existing Warrants," and together with the New Warrants, the "Warrants"); however, due to the exercise limitations of the Warrants, the reporting person's beneficial ownership has been limited to 985,000 shares in the aggregate.

(2) Each of the Warrants includes a provision limiting the holder's ability to exercise the Warrants if such exercise would cause the holder to beneficially own greater than 9.99% of the Company.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) The reporting person's ownership consists of (i) 191,770 shares of common stock, (ii) 961,540 New Warrants, and (iii) 47,059 Existing Warrants.

(2) Each of the Warrants includes a provision limiting the holder's ability to exercise the Warrants if such exercise would cause the holder to beneficially own greater than 9.99% of the Company.


SCHEDULE 13G



Comment for Type of Reporting Person:  (1) The reporting person's ownership consists of (i) 191,770 shares of common stock, (ii) 961,540 New Warrants, and (iii) 47,059 Existing Warrants.

(2) Each of the Warrants includes a provision limiting the holder's ability to exercise the Warrants if such exercise would cause the holder to beneficially own greater than 9.99% of the Company.


SCHEDULE 13G


 
Lind Global Fund II LP
 
Signature:By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton
Name/Title:Jeff Easton, Managing Member
Date:02/14/2025
 
Lind Global Partners II LLC
 
Signature:/s/ Jeff Easton
Name/Title:Jeff Easton, Managing Member
Date:02/14/2025
 
EASTON JEFF
 
Signature:/s/ Jeff Easton
Name/Title:Jeff Easton
Date:02/14/2025
Exhibit Information

99.1 Joint Filing Application by and among the Reporting Persons.

primary_doc.xml